a public good project by the
Synthesis
Company
of California

© 2026

Shudan Zheng | doi.page

0 works0 citations0 h-index

Shudan Zheng

Jiangnan University(CN)Nanjing Medical University(CN)Nanjing University(CN)

Publications by Year

Research Areas

Cancer-related molecular mechanisms research, Mesenchymal stem cell research, Liver Disease Diagnosis and Treatment, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Galectins and Cancer Biology

Most-Cited Works

→ A review of signal pathway induced by virulent protein CagA of Helicobacter pylori(2023)50 cited
→ A miR-1231 binding site polymorphism in the 3′UTR of IFNAR1 is associated with hepatocellular carcinoma susceptibility(2012)39 cited
→ Increased expression of OPN contributes to idiopathic pulmonary fibrosis and indicates a poor prognosis(2023)39 cited
→ GNB2L1 and its O-GlcNAcylation regulates metastasis via modulating epithelial-mesenchymal transition in the chemoresistance of gastric cancer(2017)28 cited
→ Advances in genetic variation in metabolism-related fatty liver disease(2023)17 cited
→ The regulatory role of bile acid microbiota in the progression of liver cirrhosis(2023)15 cited

→ Altered striatal rhythmic activity in cylindromatosis knock-out mice due to enhanced GABAergic inhibition(2016)

13 cited

→ A Functional Insertion/Deletion Polymorphism in the Promoter of PDCD6IP Is Associated with the Susceptibility of Hepatocellular Carcinoma in a Chinese Population(2013)11 cited

→ An insertion/deletion polymorphism in the interleukin-1A 3'untranslated region confers risk for gastric cancer(2016)10 cited

→ M2 macrophage-targeted metal-polyphenol networks (MPNs) for OPN siRNA delivery and idiopathic pulmonary fibrosis therapy(2025)6 cited